Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response
Background Cisplatin-induced peripheral neuropathy (CIPN) is a frequent serious dose-dependent adverse event that can determine dosage limitations for cancer treatment. CIPN severity correlates with the